Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Successful application of antedrug approach to the development of topical antiinflammatory agents

April 27, 2000

Abbott and Chrysalis BioTechnology collaborate on Chrysalin development

April 26, 2000

Faulding obtains Australian rights to ConXn

April 19, 2000

Apligraf PMA supplement tentatively scheduled for FDA review in May

April 11, 2000

New compounds from Japanese lab inhibit Th2-type cytokine production

April 7, 2000

FDA gives go-ahead for Access to commence OraDisc clinical trials

April 5, 2000

Chemokine receptor modulators in early development at AstraZeneca

April 5, 2000

First phase II clinical trial of ABX-IL-8 begins in psoriasis

April 5, 2000

Draxis seeks approval of Levulan PDT in Canada

March 31, 2000

Organogenesis receives milestone payment related to Apligraf progress

March 30, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026